Anthony L. Boral is Chief Medical Officer at Blueprint Medicines Corp (BPMC). They have made 11 open-market trades across 1 company since 2017, most recently 2020-12-14.
CIK 0001638468
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 11 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| BPMC | 28,147 | $3.6M |
Shares reported on the most recent Form 4, priced at the 2020-12-16 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| BPMC | SELL | 2020-12-14 | 2020-12-16 | $118.54 | $2.3M | -0.6% | -14.0% | -11.8% |
| BPMC | SELL | 2020-09-22 | 2020-09-24 | $82.33 | $1.1M | +10.6% | +18.1% | +42.5% |
| BPMC | SELL | 2020-09-17 | 2020-09-21 | $80.00 | $1.9M | +14.1% | +21.7% | +47.8% |
| BPMC | SELL | 2020-03-09 | 2020-03-11 | $51.97 | $28K | +6.0% | +32.0% | +51.7% |
| BPMC | SELL | 2019-12-17 | 2019-12-19 | $76.57 | $1.5M | +5.4% | +2.2% | -30.8% |
| BPMC | SELL | 2019-08-20 | 2019-08-22 | $80.07 | $801K | -2.6% | +4.0% | -2.1% |
| BPMC | SELL | 2019-07-08 | 2019-07-10 | $93.88 | $1.9M | +2.5% | -5.5% | -25.8% |
| BPMC | SELL | 2017-11-06 | 2017-11-08 | $70.17 | $624K | -2.9% | +4.1% | +11.8% |
| BPMC | SELL | 2017-08-09 | 2017-08-11 | $48.61 | $481K | +8.8% | +4.0% | +50.5% |
| BPMC | SELL | 2017-06-28 | 2017-06-30 | $50.65 | $451K | +3.9% | +2.6% | +34.2% |
| BPMC | SELL | 2017-06-28 | 2017-06-30 | $50.47 | $505K | +3.9% | +2.6% | +34.2% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.